EMAIL US: customerservice@franklinyoung.com
CALL US: (618) 724-2780 / (909) 931-5012
CALL US: (618) 724-2780 / (909) 931-5012
Back to Previous Page
ITEM#: 3042-Y0001365
MFR#: Y0001365
Etoposide for system suitability
| Product Name | Description | Item# | QTY | |
|---|---|---|---|---|
Etoposide
|
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-1268808300MG | EA | |
Etoposide
|
Etoposide | 3042-E2600000 | EA | |
Etoposide quinone
|
Etoposide-quinone is a major metabolite of anticancer drug etoposide, which may contribute to the development of secondary acute myeloid leukemias in some etoposide patients. Etoposide-quinone is a covalent poison of human topoisomerase IIb, which in | 3042-SMB00960250MG | EA | |
Etoposide quinone
|
Etoposide-quinone is a major metabolite of anticancer drug etoposide, which may contribute to the development of secondary acute myeloid leukemias in some etoposide patients. Etoposide-quinone is a covalent poison of human topoisomerase IIb, which in | 3042-SMB0096025MG | EA | |
Dorzolamide for system suitability
|
Dorzolamide for system suitability | 3042-Y0000750 | EA |